Careers Contact Us
Facebook Twitter LinkedIn
logo_abeona_retina
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Pz-cel
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  • Patients & Families
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
    • Patient Advocacy & Community Engagement (PACE)
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us
×
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Pz-cel
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  • Patients & Families
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
    • Patient Advocacy & Community Engagement (PACE)
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Events

Investors

Investors & Media

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Scientific Advisory Board
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

  • News / Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts

Phase 3 VIITAL™ Clinical Study Topline Results Call

Nov 3, 2022 • 8:30am EST
Audio
Webcast
PDF
Presentation

© 2024 Abeona Therapeutics Inc. All Rights Reserved. | Privacy Policy Terms of Use